Should industry speak the loudest in informing the public on medical matters?
2006

Should Industry Speak the Loudest in Informing the Public on Medical Matters?

publication

Author Information

Author(s): Gordon McCarter

Primary Institution: Touro University

Hypothesis

How does the public get unbiased information to rationally choose between different treatment options for depression?

Conclusion

The current pharmaceutical advertising approach to depression treatment is misleading and does not inform patients of all available treatment options.

Supporting Evidence

  • The claim that SSRIs 'correct a chemical imbalance' is scientifically unsupported.
  • Depression is a physical disease that can be treated in many ways beyond pharmaceuticals.
  • Education for both physicians and patients is essential for better treatment choices.

Takeaway

This study says that ads for depression medicine might not tell the whole story, and people should know about other ways to feel better, like talking to a doctor or trying therapy.

Potential Biases

The knowledge environment is dominated by commercial interests, which may skew the information available to both doctors and patients.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030118

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication